“Type 1 Diabetes Development Requires Both CD4+ and CD8+ T cells and Can Be Reversed by Non-Depleting Antibodies Targeting Both T Cell Populations ” (2023) The Review of Diabetic Studies, 6(2). Available at: https://diabeticstudies.org/index.php/RDS/article/view/259 (Accessed: 13 September 2025).